DermTopic: Psoriasis

Filter Your Results

 

News

 

Avalere: Biosimilars More Expensive for Medicare Beneficiari…

Medicare beneficiaries are likely to pay more for biosimilars than for the biologic reference product in Part D under cu…

FDA Approves Inflectra, a Biosimilar to Remicade

And then there were two ... The U.S. Food and Drug Administration approved the biosimilar Inflectra (infliximab-dyyb) fo…

More Than 1,000 Patients Join Corrona Psoriasis Registry

The Corrona Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, …

FDA Greenlights Taltz for Psoriasis

The U.S. Food and Drug Administration approved the IL-17A blocker Taltz (ixekizumab) for adults with moderate-to-severe …

Vitae Achieves Proof-of-Concept with First-in-Class RORyt In…

Vitae Pharmaceuticals, Inc. shared positive top-line results from its Phase 2a proof-of-concept clinical trial of VTP-43…

Study Links Psoriasis to Bone Loss. Is IL-17 to Blame?

Psoriasis is linked to widespread bone loss, according to Researchers from the Genes, Development and Disease Group at t…

Currents

New Initiative Seeks To Raise Biosimilar Awareness, Access The Biosimilars Forum is launching a new biosimilars educa…

TherapeuticsFocus:Psoriasis

AbbVie Buys Rights to Boehringer Psoriasis Drug for $595 Million AbbVie Inc. and Boehringer Ingelheim are collaborati…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.